ONCOLOGY INTELLIGENCE
Your oncology briefing
News, evidence & guideline updates distilled for rapid professional review.
Last successful source sync17 Sep 2026 · 14:34
Source refresh is overdue. This briefing may not include recent updates.
Ongoing | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.
Verified Clinical Benefit | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit and for which traditional approval has been subsequently granted for the specific indication.
No briefing items match these filters.